Clinical Trial

Effect of I-PRF Application on ALP and MMP-9 Levels in Teeth With Apical Periodontitis

Completed
View on ClinicalTrials.gov →
Summary
The aim of this study was to evaluate the effect of injectable platelet rich fibrin (i-PRF) injection, in addition to routine root canal treatment, on alkaline phosphatase (ALP) and matrix metalloproteinase-9 (MMP-9) levels in teeth with chronic apical periodontitis. A total of 60 patients were included and randomly divided into two groups: the control group and the experimental group (i-PRF). Gingival crevicular fluid (GCF) samples and periapical exudate (PAE) samples were collected from the teeth at the first appointment, after completion of chemomechanical preparation. In both groups, calcium hydroxide was placed in the root canals, and the teeth were temporarily sealed with composite resin. While no additional procedure was performed in the control group, patients in the experimental group received submucosal i-PRF injection. The second samples were obtained after 4 weeks, and in the same session, the root canal treatment was completed, followed by permanent restoration. ALP and MMP-9 levels in the collected samples were analyzed using the ELISA test.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-27.
Trial Details
NCT Number NCT07320898
Lead Sponsor Kırıkkale University
Conditions Apical Periodontitis, i-PRF, Biomarkers, MMP-9, Alkaline Phosphatase
Enrollment 60 participants
Start Date 2025-01-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-10-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-31